Research and development organization specializing in novel analgesics and anti-hyperalgesic therapeutics. The bulk of revenue is derived from activity in the pharmaceuticals industry. This company was capitalized by venture capital. Stock symbol: ADLR. Products include anti-hyperalgesic therapy R&D, Novel analgesic R&D.